| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/20/2010 | EP1117419B1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | CN100582771C Chinese medicinal soft capsule effective ingredient detection method |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581574C Medicine for treating pulmonary tuberculosis |
| 01/20/2010 | CN100581561C Asiatic moonseed extract, preparations, preparing method and use thereof |
| 01/20/2010 | CN100581560C Cold-treating medicine and preparation method thereof |
| 01/20/2010 | CN100581545C Siromosi medicinal composition and its making method |
| 01/20/2010 | CN100581375C Lung-clearing tea and preparation method thereof |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648992 Metalloproteinase 9 and/or 12 inhibitors; such as 5-({[4-[(2-cyclopropylpyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H1)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; synthesis; asthma, chronic obstructive pulmonary disease |
| 01/19/2010 | US7648988 6-Chloro-2-piperazino-4-pyrrolidinopteridine derivatives; brain, nervous system, respiratory system, gastrointestinal, and psychological disorders; arthritis, antiasthmatics, cancer, leukemia, pain; Crohn's, Alzheimer's, and Parkinson's disease; multiple sclerosis; joint, eye and skin disorders |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | CA2544422C Soft steroid compositions for use in dry powder inhalers |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2164517C Method of treating retained pulmonary secretions |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005770A2 Electrostatically charged nasal application multipurpose products and method |
| 01/14/2010 | WO2010005766A1 Use of pharmaceutical compositions comprising a caspase inhibitor for treating interstitial lung diseases |
| 01/14/2010 | WO2010005520A2 2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives |
| 01/14/2010 | WO2010004816A1 Inhibitor of degranulation of mast cell |
| 01/14/2010 | WO2010004517A1 Triazole derivatives useful for the treatment of diseases |
| 01/14/2010 | WO2010004319A1 Combination comprising 6-flu0r0-n- ((1s, 4s) - 4- (6-fluoro-2, 4-di0x0-1- (4'- (piperazin-1- ylmethyl) biphenyl- 3-yl) -1, 2-dihydropyrido [2, 3-d] pyrimidin-3 (4h) - yl) cyclohexyl) imidazo [1,2-a] pyridine -2- carboxamide or a salt |
| 01/14/2010 | WO2010003472A2 Lozenge composition for treating inflammatory diseases of the mouth and pharynx |
| 01/14/2010 | WO2009126530A3 Piperidine derivatives as cgrp receptor antagonists |
| 01/14/2010 | US20100010040 Triazol Derivatives Useful For The Treatment of Diseases |
| 01/14/2010 | US20100010039 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 01/14/2010 | US20100010034 Crth2 antagonists |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009951 Ciclesonide containing sterile aqueous suspension |
| 01/14/2010 | US20100009950 Substituted ethanolamines |
| 01/14/2010 | US20100009947 2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009939 Concurrent drugs |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100008997 Compositions and methods for treating asthma and other lung disorders |
| 01/14/2010 | US20100008996 Inhalative and instillative use of semifluorinated alkanes as an active substance carrier in the intrapulmonary area |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008911 Use of tgf-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2726686A1 Triazole derivatives useful for the treatment of diseases |
| 01/14/2010 | CA2726314A1 Electrostatically charged nasal application multipurpose products and method |
| 01/13/2010 | EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142183A2 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| 01/13/2010 | EP2027108B1 Histamine receptor antagonists comprising an azepin core |
| 01/13/2010 | EP1487453B1 N- ¬(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl methyl -2- 3-¬(methylsulphonyl)amino phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1341550B1 Leptin for treating respiratory distress syndrome and impaired lung surfactant production |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN201379809Y Pill |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579577C Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 01/13/2010 | CN100579565C Preparation for treating chronic pulmonary heart disease and preparation method thereof |
| 01/13/2010 | CN100579563C Oral Chinese medicine composition for treating bronchiolectasis |
| 01/13/2010 | CN100579557C Cough-stopping granule with honeysuckle flower and bulbus fritilariae |
| 01/13/2010 | CN100579539C Chinese medicine preparation for preventing upper respiratory tract infection and preparing method thereof |
| 01/13/2010 | CN100579538C Compound spray for treating rhinitis and preparation method thereof |
| 01/13/2010 | CN100579537C Centella soft capsule and its preparing method |
| 01/13/2010 | CN100579513C Preparation method of lung targeting emodin polylactic acid microsphere |
| 01/13/2010 | CN100579383C Health-care tea containing radix glehniae |
| 01/13/2010 | CN100579380C Health-care tea containing radix stemonae stemona |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2481461C Derivatives of n-[phenyl(piperidin-2-yl) methyl] benzamide, the preparation method thereof and application of same in therapeutics |
| 01/12/2010 | CA2466338C New uses for anti-malarial therapeutic agents |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2409664C Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/07/2010 | WO2010003127A2 Antagonists of prostaglandin d2 receptors |
| 01/07/2010 | WO2010003120A2 Antagonists of prostaglandin d2 receptors |
| 01/07/2010 | WO2010002965A2 Pneumonia treatment |
| 01/07/2010 | WO2010002244A1 Nutritional composition for infants delivered via caesarean section |
| 01/07/2010 | WO2010002241A1 Nutritional composition for infants delivered via caesarean section |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001933A1 Histone modification inhibitor specific to target gene |
| 01/07/2010 | WO2010001932A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010000437A1 Antiallergic marine biopolymers |
| 01/07/2010 | WO2009140204A3 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/07/2010 | WO2009138758A3 Bis-aryl compounds for use as medicaments |
| 01/07/2010 | WO2009063226A3 Methods relating to breathing disorders |
| 01/07/2010 | WO2008149168A8 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
| 01/07/2010 | US20100004628 System for delivering a composition to the nasal membrane and method of using same |